Plasma high density lipoprotein levels show a strong inverse relationship with atherosclerotic cardiovascular disease. Recently, scavenger receptor B1 (SRB1) has been identified as an authentic functional HDL receptor. SRB1 binds HDL specifically and mediates the selective uptake of HDL cholesteryl esters (CE) by cells. SRB1 is highly expressed in steroidogenic tissues which show greatest selective uptake in vivo. Recent studies show that adrenal SRB1 mRNA is upregulated in apo A-I knock-out and hepatic lipase deficient mice, but not in several other knock-out strains. Since adrenal cholesterol stores are depleted only in the mice deficient in A-I and hepatic lipase, this suggests that SRB1 mediates selective uptake specifically from HDL containing apo A-I, in a process enhanced by HL activity, and that SRB1 expression is under feedback control in response to changes in cellular cholesterol stores. The overall goals of this proposal are to elucidate the mechanisms of selective uptake by SRB1, the role of HDL remodeling by HL and cholesteryl ester transfer protein in this process, the feedback regulation of SRB1 in response to changes in cellular cholesterol pools and the role of SRB1 in lipoprotein metabolism and atherogenesis.
The specific aims are 1) to elucidate the molecular determinants of HDL binding and selective lipid uptake by SRB1; 2) to evaluate the possible feedback regulation of SRB1 in response to HDL-mediated changes in cellular cholesterol pools in adrenal and liver; 3) to use SRB1 transgenic and knock-out mice to study the role of SRB1 in selective uptake of HDL lipids, reverse cholesterol transport and atherogenesis; 4) to evaluate the potential role of SRB1 in human HDL metabolism by searching for mutations. One hypothesis that will be investigated is that SRB1 upregulation in the liver results in enhanced reverse cholesterol transport and decreased atherogenesis. The research will provide new information on the role of SRB1 in HDL metabolism and atherogenesis, and will help to define how SRB1 interacts with other components of the reverse cholesterol transport system.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058033-03
Application #
2901296
Study Section
Metabolism Study Section (MET)
Program Officer
Laughlin, Maren R
Project Start
1997-04-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Huszar, D; Varban, M L; Rinninger, F et al. (2000) Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20:1068-73
Sun, Y; Wang, N; Tall, A R (1999) Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools. J Lipid Res 40:1799-805
Ji, Y; Wang, N; Ramakrishnan, R et al. (1999) Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 274:33398-402
Arai, T; Wang, N; Bezouevski, M et al. (1999) Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 274:2366-71
Arai, T; Rinninger, F; Varban, L et al. (1999) Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci U S A 96:12050-5
Varban, M L; Rinninger, F; Wang, N et al. (1998) Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 95:4619-24
Wang, N; Arai, T; Ji, Y et al. (1998) Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 273:32920-6
Sehayek, E; Ono, J G; Shefer, S et al. (1998) Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci U S A 95:10194-9